摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-5-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine | 508169-17-3

中文名称
——
中文别名
——
英文名称
(+/-)-5-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine
英文别名
(+/-)-7-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one;2-chloroethyl [6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] carbonate
(+/-)-5-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine化学式
CAS
508169-17-3
化学式
C14H10Cl2N4O4
mdl
——
分子量
369.164
InChiKey
SFQUAPARFCAVAN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    94.5
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (+/-)-5-(2-chloroethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine吡啶 、 phosphate buffer 、 Candida antarctica lipase B Novozym 435 作用下, 以 甲苯 为溶剂, 反应 96.0h, 生成 (+/-)-7-(p-nitrophenyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
    参考文献:
    名称:
    Enzymatic resolution of new carbonate intermediates for the synthesis of (S)-(+)-zopiclone
    摘要:
    The lipase from Candida antaretica B catalyzes the enantioselective hydrolysis of (+/-)-6-(5-chloropyridin-2-yl)-7-chloromethyloxycarbonyloxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one, a useful intermediate in the synthesis of (S)-(+)-zopiclone. This enzyme also catalyzes the resolution of the corresponding 2-chloroethylcarbonate derivative. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0957-4166(02)00685-7
  • 作为产物:
    参考文献:
    名称:
    Enzymatic resolution of new carbonate intermediates for the synthesis of (S)-(+)-zopiclone
    摘要:
    The lipase from Candida antaretica B catalyzes the enantioselective hydrolysis of (+/-)-6-(5-chloropyridin-2-yl)-7-chloromethyloxycarbonyloxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one, a useful intermediate in the synthesis of (S)-(+)-zopiclone. This enzyme also catalyzes the resolution of the corresponding 2-chloroethylcarbonate derivative. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0957-4166(02)00685-7
点击查看最新优质反应信息

文献信息

  • Optically active carbonates as precursors of (+)-zopiclone
    申请人:Bayod Jasanada Miguel
    公开号:US06969767B1
    公开(公告)日:2005-11-29
    In the present invention new compounds of formula II, in enantiomerically enriched forms, are described for the first time, where R 1 is chloroalkyl. The present invention also includes several new enzymatic processes for the resolution of the enantiomers of the aforementioned carbonates of formula II from the corresponding racemic mixture. The transformation of these carbonates into zopiclone enantiomerically enriched, constitutes an additional aspect of the invention.
    在本发明中,首次描述了式II的新化合物,其为对映富集形式,其中R1为氯代烷基。本发明还包括几种新的酶法过程,用于从相应的外消旋混合物中分离出式II的上述碳酸酯的对映体。将这些碳酸酯转化为对映富集的左西普克隆,构成了本发明的另一个方面。
  • Resolution of (±)-5-substituted-6-(5-chloropyridin-2-yl)-7-oxo-5,6-dihydropyrrolo[3,4b]pyrazine derivatives-precursors of (S)-(+)-Zopiclone, catalyzed by immobilized Candida antarctica B lipase in aqueous media
    作者:Jose M Palomo、Cesar Mateo、Gloria Fernández-Lorente、Laura F Solares、Monica Diaz、Vı́ctor M Sánchez、Miguel Bayod、Vicente Gotor、Jose M Guisan、Roberto Fernandez-Lafuente
    DOI:10.1016/s0957-4166(02)00867-4
    日期:2003.2
    The enzymatic resolution of different cyclopyrrolone compounds has been performed in aqueous systems using different immobilized preparations of lipase from Candida antarctica (fraction B). The relevance of the immobilizaition protocol in the results has been shown: lipase immobilized on octadecyl-Sepabeads gave the highest stability and enantioselectivity. Commercial Novozym 435 was scarcely enantioselective in the hydrolytic process. On the other hand, the structure of the cyclopyrrolone was also found to be very important to the outcome of the reaction, the best results being achieved with compounds (+/-)-l and (+/-)-2. Thus. using compound (+/-)-2. a ee(s) of < 95% can be achieved under conditions in which the enzyme preparation can be utilized in 10 recycles without any significant detriment to the enzymatic properties (activity, enantioselectivity). Moreover, this enzyme catalyzes the hydrolytic resolution of chloromethyl carbonate (+/-)-5, a useful intermediate for the synthesis of the hypnotic agent (S)-(+)-Zopiclone. (C) 2003 Elsevier Science Ltd. All rights reserved.
  • Methods and compositions for the treatment of neurodegenerative disorders
    申请人:Jin Xiaowei
    公开号:US20080044390A1
    公开(公告)日:2008-02-21
    The present invention features compositions, kits, and methods for treating, preventing, and ameliorating neurodegenerative disorders, e.g., Huntington's disease.
  • US6969767B1
    申请人:——
    公开号:US6969767B1
    公开(公告)日:2005-11-29
  • Enzymatic resolution of new carbonate intermediates for the synthesis of (S)-(+)-zopiclone
    作者:Laura F. Solares、Mónica Dı́az、Rosario Brieva、Vı́ctor M. Sánchez、Miguel Bayod、Vicente Gotor
    DOI:10.1016/s0957-4166(02)00685-7
    日期:2002.11
    The lipase from Candida antaretica B catalyzes the enantioselective hydrolysis of (+/-)-6-(5-chloropyridin-2-yl)-7-chloromethyloxycarbonyloxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one, a useful intermediate in the synthesis of (S)-(+)-zopiclone. This enzyme also catalyzes the resolution of the corresponding 2-chloroethylcarbonate derivative. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

舒立克隆 吡唑并[1,5-a]吡咯并[2,1-C]吡嗪 吡咯并[1,2-a]噻吩并[2,3-e]吡嗪 吡咯并[1,2-a]吡嗪-8-甲醛 吡咯并[1,2-a]吡嗪-6-甲醛(9CI) 吡咯并[1,2-a]吡嗪-3-羧酸乙酯 吡咯并[1,2-a]吡嗪-3-羧酸 吡咯并[1,2-a]吡嗪 吡咯并[1,2-A]吡嗪-6-甲醇 右佐匹克隆 佐匹克隆氧化物 佐匹克隆杂质3 佐匹克隆 二羰雙吡咯 乙酰氨基-6-吡咯并[1,2-a]噻吩并[2,3-e]吡嗪 乌帕替尼 N-甲基-5-溴-4,7-二氮杂吲哚 N-去甲基佐匹克隆 7-碘-5H-吡咯并[2,3-b]吡嗪 7-甲基-6,8-二(甲硫基)吡咯并[1,2-a]吡嗪 7-氯甲基氧基-羰基氧基-6-(5-氯吡啶-2-基)-6,7-二氢-5H-吡咯并[3,4-b]吡嗪-5-酮 6-甲基-吡咯并[1,2-a]吡嗪 6-溴吡咯[1,2-A]吡嗪-3-羧酸乙酯 6-(7-氯-1,8-萘啶-2-基)-6,7-二氢-7-羟基-5H-吡咯并[3,4-b]吡嗪-5-酮 6-(7-氯-1,8-萘啶-2-基)-2,3,6,7-四氢-7-羟基-5H-1,4-二噻英并[2,3-c]吡咯-5-酮 6-(5-氯-吡啶-2-基)-7-苯氧基羰基氧基-6,7-二氢-吡咯并3,4-b吡嗪-5-酮 6-(5-氯-2-吡啶基)-6,7-二氢-7-羟基-5H-吡咯并[3,4-b]吡嗪-5-酮 6-(5-氯-1,8-萘啶-2-基)-2,3,6,7-四氢-7-氧代-5H-1,4-二噻英并[2,3-c]吡咯-5-基4-甲基哌嗪-1-羧酸酯 6,7,8,9-四氢吡嗪并[1,2-A]吲哚-1(2H)-酮 5H-吡嗪并[2,3-b]吲哚 5H-吡咯并[2,3-b]吡嗪-7-羧醛 5H-吡咯并[2,3-b]吡嗪-2-羧酸甲酯 5H-吡咯[2,3-B]吡嗪-7-乙酸 5-溴-4,7-二氮杂吲哚 5-氯-2-(7-氯-1,8-萘啶-2-基)-3-羟基异吲哚啉-1-酮 5-氢吡咯并[2,3-b]吡嗪-7-甲酸 4,7-二氮杂吲哚 3-羟基-2-(7-甲氧基-[1,8]萘啶-2-基)-2,3-二氢-异吲哚-1-酮 3-甲基吡咯并[1,2-a]吡嗪-1(2H)-酮 3-溴-5H-吡咯并[2,3-b]吡嗪 3-溴-4,7-二氮杂吲哚 3-氯-5H-吡咯并[2,3-b]吡嗪 3,6,7-三甲基吡咯并[1,2-a]吡嗪 2-溴-7-碘-5H-吡咯并[2,3-B]吡嗪 2-溴-7-硝基-5H-吡咯并[2,3-B]吡嗪 2-溴-6-甲基-5H-吡咯并[2,3-b]吡嗪-7-羧酸乙酯 2-溴-6-甲基-5H-吡咯并[2,3-B]吡嗪-7-羧酸甲酯 2-溴-5H-吡咯并[2,3-b]吡嗪-7-羧酸甲酯 2-溴-5H-吡咯并[2,3-b]吡嗪-7-羧酸 2-溴-5H-吡咯并[2,3-B]吡嗪-7-胺